Pharsight

Hospira Inc patents expiration

1. Daptomycin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10357535 HOSPIRA INC Daptomycin formulations and uses thereof
Sep, 2033

(9 years from now)

US9655946 HOSPIRA INC Daptomycin formulations and uses thereof
Sep, 2033

(9 years from now)

Drugs and Companies using DAPTOMYCIN ingredient

Market Authorisation Date: 21 June, 2021

Treatment: Treatment of complicated skin and skin structure infections and s. aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis by reconstituting and administerin...

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

DAPTOMYCIN family patents

Family Patents